X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (533) 533
Publication (63) 63
Newspaper Article (4) 4
Book / eBook (2) 2
Conference Proceeding (2) 2
Book Chapter (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (240) 240
humans (234) 234
index medicus (229) 229
female (151) 151
male (147) 147
aged (118) 118
heart failure (115) 115
cardiovascular (112) 112
mortality (112) 112
abridged index medicus (103) 103
middle aged (92) 92
risk factors (82) 82
atrial fibrillation (79) 79
treatment outcome (76) 76
defibrillators (73) 73
care and treatment (72) 72
implantable cardioverter-defibrillator (65) 65
defibrillators, implantable (59) 59
sudden cardiac death (59) 59
cardiology (58) 58
cardiac arrhythmia (56) 56
article (54) 54
prevention (54) 54
heart (52) 52
death, sudden, cardiac - prevention & control (51) 51
united states (51) 51
heart attacks (50) 50
implants, artificial (48) 48
internal medicine (48) 48
prosthesis (48) 48
risk (46) 46
stroke (46) 46
analysis (45) 45
catheter ablation (45) 45
registries (45) 45
therapy (44) 44
cardiac patients (43) 43
risk assessment (43) 43
heart failure - therapy (42) 42
heart-failure (42) 42
peripheral vascular disease (42) 42
drug therapy (41) 41
aged, 80 and over (39) 39
cardiac resynchronization therapy (39) 39
cardiovascular disease (39) 39
clinical medicine (38) 38
patients (38) 38
clinical trials (37) 37
electrocardiography (37) 37
usage (37) 37
guidelines (36) 36
outcomes (36) 36
united states - epidemiology (36) 36
medicare (35) 35
retrospective studies (35) 35
myocardial-infarction (34) 34
primary prevention (33) 33
acc/aha clinical practice guidelines (32) 32
myocardial infarction (31) 31
disease (30) 30
follow-up studies (30) 30
patient outcomes (30) 30
survival (30) 30
atrial fibrillation - drug therapy (29) 29
medical research (29) 29
death (28) 28
management (28) 28
warfarin (28) 28
heart failure - mortality (27) 27
medical and health sciences (27) 27
medicin och hälsovetenskap (27) 27
proportional hazards models (27) 27
ventricular tachycardia (27) 27
implantable cardioverter defibrillator (26) 26
cardiomyopathy (25) 25
registry (25) 25
medicine, general & internal (24) 24
acute myocardial-infarction (23) 23
adult (23) 23
hospitalization (23) 23
implantable cardioverter-defibrillators (23) 23
incidence (23) 23
anticoagulants - therapeutic use (22) 22
cardiac arrest (22) 22
medicine, experimental (22) 22
research (22) 22
time factors (22) 22
anti-arrhythmia agents - therapeutic use (21) 21
atrial fibrillation - complications (21) 21
health aspects (21) 21
heart beat (21) 21
hypertension (21) 21
randomized controlled trials as topic (21) 21
stroke - prevention & control (21) 21
aha scientific statements (20) 20
anticoagulants (20) 20
arrhythmia (20) 20
association task-force (20) 20
comorbidity (20) 20
medical colleges (20) 20
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 10/2019, Volume 394, Issue 10206, pp. 1302 - 1304
[...]nearly 40% of potentially eligible patients were excluded because they were not in sinus rhythm or had poor-quality electrocardiograms, which raises... 
PREVENTION | MEDICINE, GENERAL & INTERNAL | CARDIOVERTER-DEFIBRILLATOR | CARDIAC DEATH | SUDDEN | DISPARITIES | Studies | Electrocardiography | Defibrillators | Patients | Mortality
Journal Article
Circulation, ISSN 0009-7322, 11/2019, Volume 140, Issue 19, pp. 1540 - 1542
Journal Article
American Heart Journal, ISSN 0002-8703, 11/2019, Volume 217, pp. 131 - 139
The subcutaneous implantable cardioverter defibrillator (S-ICD) is a completely extrathoracic device that has recently been FDA approved for the prevention of... 
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2019
Journal Article
American Heart Journal, ISSN 0002-8703, 2010, Volume 159, Issue 3, pp. 331 - 339
Atrial fibrillation (AF) is associated with increased risk of stroke that can be attenuated with vitamin K antagonists (VKAs). Vitamin K antagonist use is... 
Cardiovascular | XIMELAGATRAN | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTICOAGULATION CONTROL | WARFARIN | ANTITHROMBOTIC THERAPY | PREVENTION | RISK | HEPARIN | ASPIRIN | FACTOR XA INHIBITOR | ANTIPLATELET THERAPY | Pyrazoles - therapeutic use | Factor Xa Inhibitors | Follow-Up Studies | Humans | Middle Aged | Warfarin - adverse effects | Warfarin - therapeutic use | Young Adult | Fibrinolytic Agents - adverse effects | Thromboembolism - prevention & control | Fibrinolytic Agents - therapeutic use | Adult | Pyrazoles - adverse effects | Stroke - prevention & control | Atrial Fibrillation - drug therapy | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | International Normalized Ratio | Adolescent | Aged | Pyridones - therapeutic use | Hemorrhage - chemically induced | Research Design | Pyridones - adverse effects | Stroke (Disease) | Clinical trials | Medical colleges | Warfarin | Atrial fibrillation | Risk factors | Health care | Anticoagulants | Cardiac arrhythmia | Stroke | Mortality | Thrombosis | Joint replacement surgery | Disease prevention | Blood platelets | Biomarkers | Blood pressure | Diabetes | Drug therapy | Drug dosages | Pyrazoles | Pyridones | Factor Xa | Fibrinolytic Agents | Hemorrhage | Life Sciences | Thromboembolism | Atrial Fibrillation | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9855, pp. 1749 - 1758
Journal Article
Journal of Cardiovascular Electrophysiology, ISSN 1045-3873, 11/2019, Volume 30, Issue 11, pp. 2420 - 2426
Background Centers for Medicare and Medicaid Services has mandated the use of shared decision‐making (SDM) for implantable cardioverter‐defibrillator (ICD)... 
sex‐ and race‐based differences | physician survey | shared decision‐making | ICD implantation | Usage | Defibrillators | Medicaid | Implants, Artificial | Prosthesis | Physicians | Decision making | Sex | Perceptions | Implantation | Risk perception | End of life | Patients | Surveys | Government programs | Race | Perception
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2016, Volume 67, Issue 13, pp. e27 - e115
Journal Article
Trends in Cardiovascular Medicine, ISSN 1050-1738, 05/2018, Volume 28, Issue 4, pp. 308 - 309
Journal Article
American Heart Journal, ISSN 0002-8703, 08/2019
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2019, Volume 73, Issue 9, pp. 3010 - 3010
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2019, Volume 73, Issue 9, p. 3010
Journal Article
Journal of Arrhythmia, ISSN 1880-4276, 02/2016, Volume 32, Issue 1, pp. 1 - 28
Cardiovascular | Programming | Tachycardia detection | Implantable cardioverter-defibrillator | Tachycardia therapy | Defibrillation testing | Bradycardia mode and rate | premature ventricular contraction | left ventricle | myocardial infarction | LVEF | S‐ICD | odds ratio | left ventricular ejection fraction | electrogram | New York Heart Association | atrial fibrillation | managed ventricular pacing | peak endocardial acceleration | NYHA | heart failure | cardiac resynchronization therapy | EEG | NCDR | randomized clinical trial | supraventricular tachycardia | adaptive cardiac resynchronization therapy | cardiac resynchronization therapy–defibrillator | ventricular tachycardia (Heart Rhythm 2015;0:1–37) | subcutaneous implantable cardioverter‐defibrillator | RCT | CRT | defibrillation testing | MVP | sudden cardiac death | National Cardiovascular Data Registry | SVT | cycle length | electroencephalography | ventricular fibrillation | CRT‐D | antitachycardia pacing | aCRT | EGM | transient ischemic attack | ICD | implantable cardioverter‐defibrillator | PEA | TIA | right ventricle | SCD | hazard ratio | confidence interval | PVC | ATP | CI, confidence interval | LVEF, left ventricular ejection fraction | VT, ventricular tachycardia (Heart Rhythm 2015;0:1–37) | PEA, peak endocardial acceleration | DT, defibrillation testing | VF, ventricular fibrillation | MI, myocardial infarction | AF, atrial fibrillation | HF, heart failure | PVC, premature ventricular contraction | MVP, managed ventricular pacing | RCT, randomized clinical trial | NCDR, National Cardiovascular Data Registry | NYHA, New York Heart Association | LV, left ventricle | HR, hazard ratio | SCD, sudden cardiac death | Guideline | EGM, electrogram | TIA, transient ischemic attack | ICD, implantable cardioverter-defibrillator | OR, odds ratio | ATP, antitachycardia pacing | CRT-D, cardiac resynchronization therapy–defibrillator | RV, right ventricle | CL, cycle length | EEG, electroencephalography | CRT, cardiac resynchronization therapy | S-ICD, subcutaneous implantable cardioverter-defibrillator | SVT, supraventricular tachycardia | aCRT, adaptive cardiac resynchronization therapy
Journal Article